XML 54 R44.htm IDEA: XBRL DOCUMENT v3.23.1
Revenue Interest Purchase Agreement - Additional Information (Details) - Purchase Agreement - OrbiMed - USD ($)
3 Months Ended
Sep. 12, 2022
Mar. 31, 2023
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]    
Upfront payment received $ 125,000,000.0  
Potential revenue interest second payment to be received $ 75,000,000  
Purchase agreement, second payment date Sep. 12, 2025  
Potential revenue interest third payment to be received $ 50,000,000.0  
Purchase agreement, third payment date Sep. 12, 2025  
Revenue interest payment term 45 days  
Amortization of purchase agreement obligation   $ 0
Effective interest rate   11.40%
Debt issuance costs   $ 600,000
Revenue interest payable   $ 1,883,000
Maximum    
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]    
Potential revenue interest payment to be received $ 125,000,000.0